Technical Analysis for MDSO - Medidata Solutions, Inc.

Grade Last Price % Change Price Change
grade D 69.46 1.98% 1.35
MDSO closed up 1.98 percent on Friday, January 18, 2019, on 1.68 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical MDSO trend table...

Date Alert Name Type % Chg
Jan 18 Weak + Overbought Other 0.00%
Jan 18 Outside Day Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 Weak + Overbought Other 1.98%
Jan 17 Overbought Stochastic Strength 1.98%
Jan 16 Stochastic Reached Overbought Strength 0.78%
Jan 16 Weak + Overbought Other 0.78%
Jan 16 Overbought Stochastic Strength 0.78%
Jan 15 Crossed Above 20 DMA Bullish 1.19%
Jan 15 Overbought Stochastic Strength 1.19%

Older signals for MDSO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences organizations in the United States and internationally. The company's solutions comprise software and services that allow customers to increase the value of their clinical development by designing, planning, and managing key aspects of the clinical trial process, including study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding, clinical business analytics, and data flow and interoperability. It offers Medidata Rave, a platform for capturing and managing clinical data; Medidata CTMS, a clinical trial management solution that streamlines operational workflows; Medidata Designer, a study and protocol design tool that enhances the efficiency of clinical trial start-up; Medidata Insights, a business analytics platform; and Medidata Balance, a randomization and trial supply management solution. The company also provides Medidata Grants Manager, which enables to develop and manage trial budgets; Medidata contract research organization (CRO) Contractor, an analytical tool for CRO outsourcing, budgeting, and negotiation; and iMedidata, a hosted portal application that allows investigative sites and sponsor study teams to start trial activities. In addition, it offers hosting, support, and professional services. The company serves pharmaceutical, biotechnology, medical device, and diagnostics companies, as well as institutions, clinical research organizations, and other entities engaged in clinical trials. Medidata Solutions, Inc. markets and sells its application services through a direct sales force, as well as through relationships with CROs and other strategic partners. The company was founded in 1999 and is headquartered in New York, New York.
Is MDSO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 88.87
52 Week Low 59.6
Average Volume 460,544
200-Day Moving Average 74.8186
50-Day Moving Average 69.967
20-Day Moving Average 66.0505
10-Day Moving Average 67.563
Average True Range 2.5353
ADX 18.95
+DI 19.9809
-DI 20.0973
Chandelier Exit (Long, 3 ATRs ) 62.7041
Chandelier Exit (Short, 3 ATRs ) 67.7059
Upper Bollinger Band 70.6293
Lower Bollinger Band 61.4717
Percent B (%b) 0.87
BandWidth 13.864543
MACD Line -0.2901
MACD Signal Line -0.9277
MACD Histogram 0.6376
Fundamentals Value
Market Cap 3.93 Billion
Num Shares 56.6 Million
EPS 0.62
Price-to-Earnings (P/E) Ratio 112.03
Price-to-Sales 8.38
Price-to-Book 9.63
PEG Ratio 2.80
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 72.39
Resistance 3 (R3) 72.09 70.83 71.90
Resistance 2 (R2) 70.83 70.08 70.97 71.73
Resistance 1 (R1) 70.14 69.62 70.49 70.44 71.57
Pivot Point 68.88 68.88 69.05 69.02 68.88
Support 1 (S1) 68.19 68.13 68.54 68.49 67.35
Support 2 (S2) 66.93 67.67 67.07 67.19
Support 3 (S3) 66.24 66.93 67.02
Support 4 (S4) 66.54